Global Immuno-oncology Assay Market By Region
| Label | Cancer Diagnosis | Clinical Trials | Patient Stratification | Therapeutic Monitoring |
|---|---|---|---|---|
| 2019 | 47.7293 USD Million | 28.035 USD Million | 23.3691 USD Million | 35.0447 USD Million |
| 2020 | 42.6721 USD Million | 25.4875 USD Million | 21.0661 USD Million | 31.062 USD Million |
| 2021 | 47.7076 USD Million | 28.9713 USD Million | 23.7468 USD Million | 34.424 USD Million |
| 2022 | 52.7401 USD Million | 32.5574 USD Million | 26.4686 USD Million | 37.7174 USD Million |
| 2023 | 58.1129 USD Million | 36.4624 USD Million | 29.4057 USD Million | 41.1848 USD Million |
| 2024 | 63.9712 USD Million | 40.7903 USD Million | 32.6368 USD Million | 44.921 USD Million |
| 2025 | 69.4845 USD Million | 44.9431 USD Million | 35.7468 USD Million | 48.3957 USD Million |
| 2026 | 75.4233 USD Million | 49.614 USD Million | 39.1177 USD Million | 51.9969 USD Million |
| 2027 | 81.825 USD Million | 54.7194 USD Million | 42.7836 USD Million | 55.8351 USD Million |
| 2028 | 88.7221 USD Million | 60.295 USD Million | 46.7682 USD Million | 59.9235 USD Million |
| 2029 | 96.1486 USD Million | 66.3791 USD Million | 51.0971 USD Million | 64.2759 USD Million |
| 2030 | 104.1408 USD Million | 73.0127 USD Million | 55.7973 USD Million | 68.9068 USD Million |
| 2031 | 112.7371 USD Million | 80.2395 USD Million | 60.898 USD Million | 73.831 USD Million |
| 2032 | 121.9782 USD Million | 88.1065 USD Million | 66.4306 USD Million | 79.0644 USD Million |
| 2033 | 131.907 USD Million | 96.6635 USD Million | 72.4283 USD Million | 84.623 USD Million |
| 2034 | 142.5688 USD Million | 105.964 USD Million | 78.9268 USD Million | 90.5239 USD Million |
| 2035 | 154.0117 USD Million | 116.0648 USD Million | 85.9645 USD Million | 96.7846 USD Million |
Data Source: Wantstats Repository
Growth Outlook
- The oncology Assay Market By Application portion of the Global Immuno market is on a steady long-term growth path. Segment value stands at roughly USD 216 Million in 2026 and is projected to reach USD 453 Million by 2035 — a gain of about 109% over the forecast period, translating to a CAGR in the high single digits.
- What the regional split looks like (2026): Cancer Diagnosis leads, holding roughly 35% of segment value — the single largest regional share. Therapeutic Monitoring is the second-largest contributor. Clinical Trials and Patient Stratification make up the remainder, in descending order.
- By 2035, Cancer Diagnosis alone is expected to reach USD 154 Million, with Clinical Trials at USD 116 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
USD49
Buy NowPowering the world's best teams.
From next-gen startups to established enterprises.
Contact us
Get in Touch
Let's work together
support@wantstats.comWantstats Research and Media Pvt. Ltd., Office No 104, Pentagon 4, Magarpatta City, Pune - 411028, Maharashtra, India.
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



